Beta-siteAPP cleaving enzyme1 (BACE1) catalyzes [117,118, 119] the ratedetermining step in the generation of Aβ peptide and is widelyconsidered as a potential therapeutic target for AD. The gene discussed is BACE1; the disease is Alzheimer disease.